AACC uses Cookies to ensure the best website experience. Continuing without changing Cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy

Onsite Program Schedule

28th AACC International CPOCT Symposium

Emerging and Current Trends in Point-of-Care Technologies: Making Faster and Better Decisions

*Please note that this program schedule is subject to change.

Wednesday, September 30, 2020

4:00–8:00 pm Registration
5:30–7:00 pm Meet and Greet Reception

Keynote Lecture

Moderator: L.V. Rao, PhD, FAACC (Planning Committee Chair)
7:00–7:05 pm Moderator Introduction
7:05–8:00 pm The State of the Art and Challenges in the Development of Point of Care Testing Technologies
Chenzhong Li, PhD

Professor & Director Department of Biomedical Engineering, Florida International University, Florida, USA.
Program Director, Biosensing Program, National Science Foundation
Alexandria, VA, USA

Thursday, October 1, 2020

7:30–9:00 am Breakfast

Session 1: Changing face of POCT applications and technological advancements

Moderator: Nichole Korpi-Steiner, PhD, DABCC, FAACC
9:00–9:05 am Moderator Introduction
9:05–9:55 am Paper based infield blood sample separation and transport
Katherine Klapperich, PhD
Professor, Department of Biomedical Engineering
Director of Center for Future Technologies in Cancer Care, Boston University
Boston, MA, USA
9:55–10:45 am Emerging Microfluidics-based Point of Care Technologies for Infectious Diseases and Beyond
Ping Wang, PhD, DABCC, FAACC

Chief of Clinical Chemistry and Core Laboratory,
Pathology and Lab Medicine,
University of Pennsylvania Perelman School of Medicine
Philadelphia, PA, USA
10:45–11:00 am Break and Visit Exhibitors
11–11:50 am Lab-on-chip system development for Chronic disease Diagnosis (CKD and COPD assessment)
Francis Lin, PhD

Associate Professor
Department of Physics and Astronomy; Immunology,
University of Manitoba
Winnipeg, MB, Canada
11:50 am–1:30 pm Lunch and Visit Exhibitors

Session 2: Informatics and IT based advances in Point of care testing

Moderator: Lilah Evans, MT(ASCP), CPP
1:30–1:35 pm
Moderator Introduction
1:35–2:25 pm Cell based Point of care diagnostics for Cancer detection using tools of precision medicine
John T. McDevitt, PhD

Chair, Department of Biomaterials, and Tandon School of Engineering, New York University
Bioengineering Institute
New York, NY, USA
2:25–3:15 pm Machine Learning Enhanced Point-of-Care Testing: The Promise and Potential Pitfalls of Artificial Intelligence
Nam K. Tran, PhD, HCLD (ABB), FACB

Associate Clinical Professor
Director of Clinical Chemistry, Special Chemistry/Toxicology, Point-of-Care Testing
Pathology and Laboratory Medicine
University of California, Davis, School of Medicine
Davis, CA, USA
3:15–3:30 pm Break and Visit Exhibitors
3:30–4:20 pm Medical Device Cybersecurity & Point of Care Solutions: What are the risks and what is being done about them?
Colin K. Morgan, CISP, CISM, GPEN

Managing Director
Apraciti LLC
Haddonfield, NJ, USA
4:30–6:30 pm Reception with Poster Viewing and Visit Exhibitors
5:30–6:30 pm Oral Presentations and Award Ceremony

Friday, October 2, 2020

7:30–8:30 am Breakfast
8:30–9:30 am Corporate Supporter Presentation
9:30–9:45 am Break and Visit Exhibitors

Session 3: Regulations

Sean Cunningham, PhD, EuSpLM 
Danyel Tacker, PhD, DABCC, FAACC
9:45–9:50 am Moderator Introduction
9:50–10:20 am Regulation of POCT devices in the European Community
Patrick M. Bossuyt, PhD

Professor of Clinical Epidemiology, Amsterdam University Medical Centers
University of Amsterdam, Netherlands
10:20–10:50 am FDA Perspectives on Devices Intended for POCT
TBD Speaker
10:50–11:20 am Regulation of POCT systems in Canada
Anna Füzéry, PhD, DABCC, FCACB 

Associate Clinical Professor of Laboratory Medicine, University of Alberta
Department of Laboratory Medicine
University of Alberta Hospital
Edmonton, AB, Canada
11:20 am–12:20 pm Panel Discussion
12:20–1:45 pm Lunch and Visit Exhibitors

Session 4: Clinical Governance

Moderator: Peggy Mann, MS, MT(ASCP), CPP
1:45–1:50 pm Moderator Introduction
1:50–2:40 pm Clinical Lab 2.0: How the Laboratory Can Support Value Based Care, Optimize Patient Outcomes, and Reduce Total Costs of Care
David G. Grenache, PhD, D(ABCC)

Chief Scientific Officer, TriCore Reference Laboratories
Medical Director, Core Laboratory
Clinical Professor of Pathology, University of New Mexico
Albuquerque, NM, USA
2:40–3:30 pm Point of care molecular testing: Multiplex nucleic acid amplification panels for infectious diseases. What’s out there now and what’s the evidence supporting clinical utility?
Robin Patel, MD(CM), D(ABMM), FIDSA, FACP, F(AAM)

Chair, Division of Clinical Microbiology
Consultant, Divisions of Clinical Microbiology and Infectious Diseases
Director, Infectious Diseases Research Laboratory
Mayo Clinic
Rochester, MN, USA
3:30–3:40 pm Break
3:40–4:30 pm Perks and Pitfalls of Point-of-Care Drug Testing
Sarah Delaney, PhD

Clinical Chemistry Fellow
Mayo Clinic
Rochester, MN, USA
4:30–4:45 pm Closing Remarks